Vaccination for Pandemic Closure

16 November 2020 |

"The coronavirus continues to spread rapidly across Europe. We need a safe and effective vaccine to end this pandemic. A few days after our contract with BioNTech and Pfizer, I am happy to announce a new agreement. Tomorrow, we will authorise a new contract to secure another COVID-19 vaccine for Europeans. This contract allows us to buy up to 405 million doses of a vaccine produced by the European company CureVac."

Read more at the link below.

RELATED LINKS

ENTERPRISE GREECE
profile icon

Company Profile

READ MORE
dioikitiko simvoulio icon

Board of Directors

READ MORE
diktio sinergaton icon

Stakeholder Network

READ MORE
epikoinonia icon

Contact us

READ MORE

LOGIN